• ATRX Loss Sensitizes High-Grade Glioma to RTK and PDGFR Inhi

  2026-07-20

  This study demonstrates that ATRX-deficient high-grade glioma cells are uniquely sensitive to receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors. Incorporating ATRX mutation status could refine therapeutic strategies and clinical trial interpretation in glioma research.

• Erastin: Validated Ferroptosis Inducer for Cancer Biology Re

  2026-07-20

  Erastin is a rigorously validated ferroptosis inducer that selectively triggers iron-dependent, non-apoptotic cell death in RAS- or BRAF-mutant tumor cells. Its unique mechanism and reproducibility make it a benchmark tool for ferroptosis research and oxidative stress assays.

• Translating BTK Inhibition: Ibrutinib (PCI-32765) in B-Cell

  2026-07-19

  This thought-leadership article examines how Ibrutinib (PCI-32765) enables precise dissection of B-cell receptor signaling and its translational impact in disease models. It synthesizes mechanistic rationale, workflow optimization, and future outlook for researchers navigating the evolving landscape of B-cell–driven pathology.

• Doxorubicin-Induced Cardiotoxicity: Mechanisms and Mitigatio

  2026-07-18

  Explore how Doxorubicin, a leading cancer chemotherapy drug, induces cardiotoxicity and the latest research-driven strategies to mitigate these effects without compromising anticancer efficacy. This article provides deep scientific insights and actionable guidance for oncology researchers.

• Erastin: Precision Ferroptosis Inducer for Advanced Cancer B

  2026-07-17

  Erastin stands out as a selective ferroptosis inducer, enabling precise dissection of oxidative cell death in RAS/BRAF-mutant tumors. This article delivers actionable workflows, troubleshooting guidance, and context from the latest research, unlocking new dimensions in ferroptosis and cancer biology research.

• Tunicamycin: Precision N-Glycosylation Inhibitor for ER Stre

  2026-07-17

  Tunicamycin stands out as the gold-standard N-glycosylation inhibitor for dissecting ER stress and inflammation pathways in cellular and animal models. With robust support from recent research and supplier-backed reproducibility, this compound enables researchers to probe mechanisms of inflammation suppression, chaperone induction, and gene expression modulation with quantitative precision.

• Hepatic sEH Regulates Osteoclastogenesis via Nrf2 in Osteopo

  2026-07-16

  A recent study uncovers how hepatic soluble epoxide hydrolase (sEH) drives osteoclast differentiation and bone loss by suppressing the Nrf2 antioxidant pathway, revealing a novel liver-bone axis in osteoporosis. These findings provide mechanistic insights into epoxyeicosatrienoic acids metabolism and suggest new avenues for intervention using sEH inhibitors.

• CCK-8 Antagonism of Electroacupuncture Analgesia and Toleran

  2026-07-16

  The reference study by Han et al. uncovers how cholecystokinin octapeptide (CCK-8) antagonizes opioid-mediated analgesia induced by electroacupuncture (EA) in rats, and establishes a mechanistic link between endogenous CCK-8 release and the development of EA tolerance. These findings provide a critical foundation for understanding anti-opioid signaling in pain modulation and have implications for designing experiments on analgesia tolerance and opioid cross-reactivity.

• Cell Counting Kit-8 (CCK-8): Precision Assay for Next-Gen Ca

  2026-07-15

  Explore how Cell Counting Kit-8 (CCK-8) advances cell viability measurement in modern cancer research. This article details unique workflow integration with programmable nanodevices, surpassing standard cytotoxicity assays.

• BMX Kinase Regulates Lysosomal Acidification in Mtb Infectio

  2026-07-15

  This study uncovers how Mycobacterium tuberculosis (Mtb) manipulates host cell survival by exploiting BMX kinase to phosphorylate the V-ATPase E1 subunit (ATP6V1E1), thereby suppressing lysosomal acidification and promoting intracellular persistence. The elucidation of this BMX-dependent mechanism highlights a novel axis of host-pathogen interaction and suggests BMX kinase as a potential therapeutic target in tuberculosis and related infectious diseases.

• SN-38 and Camptothecin Block FUBP1-FUSE Binding in Cancer Mo

  2026-07-14

  This study uncovers that camptothecin and its analog SN-38 not only inhibit DNA topoisomerase I but also prevent the oncogenic regulator FUBP1 from binding to its DNA target FUSE. These dual actions suggest new mechanistic insights for advanced colon and liver cancer research, particularly in tumors overexpressing FUBP1.

• GPR30 in Spinal CCK+ Neurons Regulates Neuropathic Pain Circ

  2026-07-14

  This study reveals that GPR30, a membrane estrogen receptor, is upregulated in spinal cholecystokinin-positive neurons following nerve injury and is essential for the amplification of neuropathic pain. Chemogenetic and molecular inhibition of GPR30 in these neuronal populations significantly alleviates pain hypersensitivity, positioning GPR30 as a promising target for future neuropathic pain therapies.

• Periodontopathogen Proteases Modulate Angiotensin I to Ang-(

  2026-07-13

  This study uncovers how key periodontopathogenic bacteria, Porphyromonas gingivalis and Tannerella forsythia, use unique surface-attached proteases to degrade angiotensin I, redirecting the host renin–angiotensin system (RAS) towards the generation of Angiotensin (1-7). The findings link oral microbial activity to systemic peptide regulation, with implications for both periodontal and broader systemic health.

• NBC19: Next-Gen NLRP3 Inflammasome Inhibitor in Inflammation

  2026-07-13

  NBC19, a nanomolar NLRP3 inflammasome inhibitor, empowers precise control over IL-1β release in advanced inflammation models. Its validated potency and workflow versatility, especially for dissecting lactate-driven macrophage signaling, make it a standout tool for translational studies and troubleshooting complex inflammasome assays.

• Central Opioid Pathways in Morphine-Induced Mechanical Hyper

  2026-07-12

  Yin et al. (2024) identified a specific brain-to-spinal opioid circuit regulating morphine-induced mechanical hypersensitivity and analgesic tolerance in mice, highlighting the pivotal role of central, rather than peripheral, opioid receptor networks. These insights suggest new experimental targets for dissecting opioid receptor signaling and pain modulation mechanisms.

13027 records 1/869 page Next 12345 下5页 Last page